Literature DB >> 27855313

Characterization of the Clostridium difficile volatile metabolome using comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.

Christiaan A Rees1, Aimee Shen2, Jane E Hill3.   

Abstract

Clostridium difficile is a bacterial pathogen capable of causing life-threatening infections of the gastrointestinal tract characterized by severe diarrhea. Exposure to certain classes of antibiotics, advanced age, and prolonged hospitalizations are known risk factors for infection by this organism. Anecdotally, healthcare providers have reported that they can smell C. difficile infections in their patients, and several studies have suggested that there may indeed be an olfactory signal associated with C. difficile-associated diarrhea. In this study, we sought to characterize the volatile molecules produced by an epidemic strain of C. difficile (R20291) using headspace solid-phase microextraction (HS-SPME) followed by two-dimensional gas chromatography time-of-flight mass spectrometry (GC×GC-TOFMS). We report on a set of 77 volatile compounds, of which 59 have not previously been associated with C. difficile growth in vitro. Amongst these reported compounds, we detect both straight-chain and branched-chain carboxylic acids, as well as p-cresol, which have been the primary foci of C. difficile volatile metabolomic studies to-date. We additionally report on novel sulfur-containing and carbonyl-containing molecules that have not previously been reported for C. difficile. With the identification of these novel C. difficile-associated volatile compounds, we demonstrate the superior resolution and sensitivity of GC×GC-TOFMS relative to traditional GC-MS.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacterial volatiles; Clostridium difficile; Clostridium difficile-associated diarrhea; GC×GC-TOFMS; Headspace volatiles; Volatile metabolomics

Mesh:

Substances:

Year:  2016        PMID: 27855313     DOI: 10.1016/j.jchromb.2016.11.009

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Comprehensive volatile metabolic fingerprinting of bacterial and fungal pathogen groups.

Authors:  Christiaan A Rees; Alison Burklund; Pierre-Hugues Stefanuto; Joseph D Schwartzman; Jane E Hill
Journal:  J Breath Res       Date:  2018-01-03       Impact factor: 3.262

2.  Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.

Authors:  Christiaan A Rees; Pierre-Hugues Stefanuto; Sarah R Beattie; Katherine M Bultman; Robert A Cramer; Jane E Hill
Journal:  J Breath Res       Date:  2017-08-21       Impact factor: 3.262

3.  Diagnosis of Clostridioides difficile infection by analysis of volatile organic compounds in breath, plasma, and stool: A cross-sectional proof-of-concept study.

Authors:  Teny M John; Nabin K Shrestha; Gary W Procop; David Grove; Sixto M Leal; Ceena N Jacob; Robert Butler; Raed Dweik
Journal:  PLoS One       Date:  2021-08-18       Impact factor: 3.240

4.  Machine learning for the meta-analyses of microbial pathogens' volatile signatures.

Authors:  Susana I C J Palma; Ana P Traguedo; Ana R Porteira; Maria J Frias; Hugo Gamboa; Ana C A Roque
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

5.  Thiol Metabolism and Volatile Metabolome of Clostridioides difficile.

Authors:  Peter Biwer; Meina Neumann-Schaal; Petra Henke; Dieter Jahn; Stefan Schulz
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

6.  Clostridioides difficile Infection Dysregulates Brain Dopamine Metabolism.

Authors:  Akhil A Vinithakumari; Piyush Padhi; Belen Hernandez; Susanne Je-Han Lin; Aaron Dunkerson-Kurzhumov; Lucas Showman; Matthew Breitzman; Caroline Stokes; Yousuf Sulaiman; Chandra Tangudu; Deepa A Kuttappan; Muhammed S Muyyarikkandy; Auriel A Willette; Gregory J Phillips; Vellareddy Anantharam; Ann Perera; Brett A Sponseller; Anumantha Kanthasamy; Shankumar Mooyottu
Journal:  Microbiol Spectr       Date:  2022-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.